Why are my breasts getting bigger as a man?

Male breast enlargement (gynecomastia) affects up to 70% of men at some point and is usually caused by hormonal imbalances between testosterone and estrogen. While often benign, it can signal underlying health issues, so testing hormone levels and consulting a healthcare provider is recommended.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Male Breast Enlargement

If you've noticed your chest area becoming fuller or developing breast tissue, you're not alone. Male breast enlargement, medically known as gynecomastia, affects between 50-70% of males at some point in their lives. This condition can range from a small amount of extra tissue around the nipples to more pronounced breast development that resembles female breasts.

Gynecomastia occurs when there's an imbalance between testosterone and estrogen levels in the male body. While men naturally produce small amounts of estrogen, when this balance shifts—either through decreased testosterone, increased estrogen, or both—breast tissue can develop. This isn't just about appearance; it can cause tenderness, pain, and significant emotional distress.

Understanding your hormone levels through comprehensive testing can provide crucial insights into what's causing these changes. Regular monitoring helps identify imbalances early and track treatment progress.

Gynecomastia Risk and Hormone Changes by Age Group

Prevalence rates vary by study. Duration depends on underlying cause and treatment.
Age GroupPrevalencePrimary CauseTypical Duration
NewbornsNewborns60-90%Maternal estrogen exposure2-3 weeks
Puberty (10-17)Puberty (10-17)50-70%Temporary hormone imbalance6 months - 2 years
Young Adults (18-30)Young Adults (18-30)10-15%Medications, substances, steroidsVaries with cause
Middle Age (40-60)Middle Age (40-60)30-40%Declining testosterone, obesityOften persistent
Elderly (60+)Elderly (60+)40-70%Low testosterone, medicationsUsually permanent

Prevalence rates vary by study. Duration depends on underlying cause and treatment.

Common Causes of Gynecomastia

Hormonal Changes Throughout Life

Hormonal fluctuations are the primary driver of gynecomastia, and these can occur at different life stages. During puberty, up to 70% of boys experience some degree of breast enlargement due to temporary hormone imbalances. This usually resolves within 6 months to 2 years. In middle-aged and older men, declining testosterone levels combined with increased body fat (which converts testosterone to estrogen) can trigger breast growth.

The following comparison shows how hormone levels and gynecomastia risk change across different age groups.

Medications and Substances

Numerous medications can cause gynecomastia as a side effect. These include:

  • Anti-androgens used for prostate conditions (finasteride, dutasteride)
  • Anabolic steroids and androgens
  • Anti-anxiety medications and antidepressants
  • Heart medications (digoxin, calcium channel blockers)
  • Stomach acid medications (cimetidine, omeprazole)
  • Chemotherapy drugs

Recreational substances also play a significant role. Alcohol consumption can increase estrogen production while decreasing testosterone. Marijuana use has been linked to gynecomastia, though the exact mechanism isn't fully understood. Heroin, amphetamines, and methadone can also contribute to breast enlargement.

Medical Conditions

Several health conditions can trigger hormonal imbalances leading to gynecomastia. Hypogonadism, where the body doesn't produce enough testosterone, is a common culprit. Hyperthyroidism accelerates metabolism and can alter hormone ratios. Liver disease impairs the body's ability to metabolize estrogen, while kidney failure can cause hormonal disruptions.

Tumors in the testes, adrenal glands, or pituitary gland can affect hormone production. Additionally, obesity increases aromatase enzyme activity, which converts testosterone to estrogen in fat tissue, creating a cycle that promotes further breast tissue development.

Distinguishing Gynecomastia from Pseudogynecomastia

Not all male breast enlargement is true gynecomastia. Pseudogynecomastia, or lipomastia, is the accumulation of fat in the chest area without actual breast gland tissue development. This distinction is important because the causes and treatments differ significantly.

True gynecomastia feels like a firm, rubbery disk of tissue directly under the nipple area. It's often tender or painful, especially when developing. The tissue feels different from surrounding fat—more dense and fibrous. It typically affects both breasts but can be unilateral in about 25% of cases.

Pseudogynecomastia, on the other hand, feels soft and uniform throughout the chest. There's no distinct mass under the nipple, and it's rarely painful. The tissue feels the same as fat elsewhere on the body. Weight loss typically reduces pseudogynecomastia, while true gynecomastia persists regardless of weight changes.

Key Hormones and Biomarkers to Test

Identifying the root cause of gynecomastia requires comprehensive hormone testing. The primary biomarkers to evaluate include testosterone (both total and free), estradiol, sex hormone-binding globulin (SHBG), and the testosterone-to-estradiol ratio. Additional markers like luteinizing hormone (LH), follicle-stimulating hormone (FSH), and prolactin help identify whether the issue originates in the testes or pituitary gland.

For a complete hormonal assessment, testing should also include DHEA-S, which indicates adrenal function, and thyroid hormones (TSH, Free T3, Free T4) since thyroid disorders can contribute to gynecomastia. Liver function tests and kidney markers may be necessary if those conditions are suspected.

The table below outlines the key hormone levels and their significance in diagnosing gynecomastia.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

When to Seek Medical Attention

While gynecomastia is often benign, certain symptoms warrant immediate medical evaluation. Seek medical attention if you experience rapid breast growth over weeks rather than months, severe or persistent pain, nipple discharge (especially if bloody), or hard, fixed lumps that feel attached to underlying tissue.

Unilateral breast enlargement (affecting only one side) requires prompt evaluation as it could indicate a tumor. Similarly, if you notice skin changes, dimpling, or nipple retraction, these could be signs of male breast cancer, which, while rare (affecting about 1 in 833 men), requires immediate attention.

Additionally, if gynecomastia develops without an obvious cause—you're not taking medications known to cause it, you're not overweight, and you're past puberty—comprehensive testing is essential to rule out underlying endocrine disorders or tumors.

Treatment Options and Management Strategies

Medical Treatments

Treatment depends on the underlying cause and severity of gynecomastia. If medications are the culprit, your doctor may adjust or change your prescription. For hormonal imbalances, testosterone replacement therapy might be appropriate if levels are clinically low. Selective estrogen receptor modulators (SERMs) like tamoxifen or raloxifene can block estrogen's effects on breast tissue.

Aromatase inhibitors such as anastrozole can reduce estrogen production, though they're typically reserved for severe cases. For prolactin-related gynecomastia, dopamine agonists may help. It's crucial to work with an endocrinologist or hormone specialist to determine the most appropriate treatment based on your specific hormone profile and medical history.

Lifestyle Modifications

Several lifestyle changes can help manage or prevent gynecomastia. Maintaining a healthy weight reduces aromatase activity in fat tissue. Regular strength training, particularly exercises targeting the chest muscles, can improve chest appearance even if breast tissue remains. Limiting alcohol consumption and avoiding recreational drugs prevents further hormonal disruption.

Dietary modifications can also help. Reduce consumption of soy products, which contain phytoestrogens, and limit processed foods high in xenoestrogens. Increase intake of cruciferous vegetables like broccoli and cauliflower, which contain compounds that help metabolize estrogen. Ensure adequate zinc and vitamin D intake, as deficiencies can affect testosterone production.

Surgical Options

When gynecomastia persists despite medical treatment or causes significant distress, surgery may be considered. Liposuction can remove excess fatty tissue in cases of pseudogynecomastia or mixed presentations. Mastectomy, either through traditional or endoscopic techniques, removes breast gland tissue. Many cases require a combination of both procedures for optimal results.

Surgery is typically considered after gynecomastia has been stable for at least 12 months and other treatments have failed. Recovery usually takes 4-6 weeks, with most men returning to normal activities within 2-3 weeks. While generally successful, potential complications include scarring, nipple sensation changes, and contour irregularities.

Prevention and Long-term Management

Preventing gynecomastia involves maintaining hormonal balance through healthy lifestyle choices. Regular exercise, particularly resistance training, helps maintain testosterone levels. Adequate sleep (7-9 hours nightly) is crucial for hormone production and regulation. Stress management through meditation, yoga, or other relaxation techniques prevents cortisol-related hormonal disruptions.

Avoid unnecessary exposure to environmental estrogens found in certain plastics, pesticides, and personal care products. Choose organic produce when possible, use glass or stainless steel containers instead of plastic, and select personal care products free from parabens and phthalates.

Regular monitoring of hormone levels, especially if you're at higher risk due to age, medications, or medical conditions, allows for early intervention. Annual or biannual testing can catch imbalances before they lead to significant breast tissue development. If you're interested in understanding your complete hormonal profile and tracking changes over time, comprehensive testing provides the insights needed for proactive health management.

For those already dealing with gynecomastia, ongoing management involves regular follow-ups with healthcare providers, continued lifestyle modifications, and psychological support if needed. Many men find that joining support groups or working with therapists specializing in body image issues helps cope with the emotional aspects of this condition.

Taking Control of Your Health

Male breast enlargement can be concerning and emotionally challenging, but understanding its causes empowers you to take appropriate action. Whether your gynecomastia stems from natural hormonal changes, medications, lifestyle factors, or underlying health conditions, identifying the root cause through proper testing is the first step toward effective management.

Remember that gynecomastia is common and treatable. With the right combination of medical evaluation, hormone testing, lifestyle modifications, and when necessary, medical or surgical intervention, most men can successfully address this condition. The key is not to ignore the symptoms or let embarrassment prevent you from seeking help.

If you're experiencing breast enlargement, start by documenting when it began, any associated symptoms, medications you're taking, and lifestyle factors that might contribute. Consider uploading your existing blood test results to SiPhox Health's free analysis service for personalized insights into your hormone levels and metabolic health. This comprehensive analysis can help identify potential imbalances and guide your next steps toward optimal health.

References

  1. Kanakis GA, Nordkap L, Bang AK, et al. EAA clinical practice guidelines-gynecomastia evaluation and management. Andrology. 2019;7(6):778-793.[PubMed][DOI]
  2. Narula HS, Carlson HE. Gynaecomastia—pathophysiology, diagnosis and treatment. Nature Reviews Endocrinology. 2014;10(11):684-698.[PubMed][DOI]
  3. Swerdloff RS, Ng CM. Gynecomastia: Etiology, Diagnosis, and Treatment. In: Feingold KR, Anawalt B, editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2022.[Link]
  4. Cuhaci N, Polat SB, Evranos B, Ersoy R, Cakir B. Gynecomastia: Clinical evaluation and management. Indian Journal of Endocrinology and Metabolism. 2014;18(2):150-158.[PubMed][DOI]
  5. Dickson G. Gynecomastia. American Family Physician. 2012;85(7):716-722.[Link][PubMed]
  6. Sansone A, Romanelli F, Sansone M, Lenzi A, Di Luigi L. Gynecomastia and hormones. Endocrine. 2017;55(1):37-44.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my testosterone and estrogen at home?

You can test your testosterone and estrogen at home with SiPhox Health's Hormone Focus Program. This CLIA-certified program includes comprehensive hormone testing including testosterone, estradiol, SHBG, and other key markers, providing lab-quality results from the comfort of your home.

Is gynecomastia reversible without surgery?

Yes, gynecomastia can often be reversed without surgery, especially if caught early. Treatment depends on the cause—stopping problematic medications, treating underlying conditions, or hormone therapy can resolve many cases. Lifestyle changes like weight loss and avoiding alcohol may help in mild cases.

What's the difference between gynecomastia and male breast cancer?

Gynecomastia is benign breast tissue growth that's usually bilateral, soft, and mobile. Male breast cancer is typically unilateral, presents as a hard, fixed mass, and may include skin changes, nipple discharge, or lymph node involvement. While rare, any concerning symptoms warrant immediate medical evaluation.

How long does pubertal gynecomastia last?

Pubertal gynecomastia typically resolves on its own within 6 months to 2 years. About 90% of cases disappear by age 17. If breast enlargement persists beyond age 17 or lasts longer than 2 years, medical evaluation is recommended to rule out other causes.

Can certain foods cause gynecomastia?

While no foods directly cause gynecomastia, some may influence hormone levels. High soy consumption (containing phytoestrogens), excessive alcohol, and foods high in xenoestrogens from pesticides or plastic packaging may contribute to hormonal imbalances. A balanced diet focusing on whole foods is recommended.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details